CVS
45
-2
QCOM
43
-7
D
58
-2
WMT
62
-2
VRSN
53
-2
LEG
11
-3
KHC
52
-2
VLO
26
-13
FLR
38
-4
NTRS
32
-12
DFS
51
-2
XYL
41
-6
MMM
32
-5
HRB
68
-3
FIS
46
-4
EMR
47
-3
FOX
37
-3
AKAM
50
-3
FMC
29
-5
ICE
66
-4
CVS
45
-2
QCOM
43
-7
D
58
-2
WMT
62
-2
VRSN
53
-2
LEG
11
-3
KHC
52
-2
VLO
26
-13
FLR
38
-4
NTRS
32
-12
DFS
51
-2
XYL
41
-6
MMM
32
-5
HRB
68
-3
FIS
46
-4
EMR
47
-3
FOX
37
-3
AKAM
50
-3
FMC
29
-5
ICE
66
-4
Financhill
Back

Evofem Biosciences 10K Form

Sell
29

EVFM
Evofem Biosciences

Last Price:
0.0100
Seasonality Move:
6.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVFM News And Ratings

See the #1 stock for the next 7 days that we like better than EVFM

EVFM Financial Statistics

Sales & Book Value

Annual Sales: $18.22M
Cash Flow: $-1.14M
Price / Cash Flow: 0
Annual Sales: $-0.84
Price / Book: 0

Profitability

EPS (TTM): -0.61750
Net Income (TTM): $60.43M
Gross Margin: $11.71M
Return on Equity: 0%
Return on Assets: 552.22%

Evofem Biosciences Earnings Forecast

Key Evofem Biosciences Financial Ratios

  • The Gross Profit Margin over the past 5 years for EVFM is 64.26%.
  • The Selling, General & Administrative Expenses for EVFM have been equal to 146.09% of Gross Profit Margin.
  • The Research & Development expenses have been 16.13% of Revenue.
  • The Interest Expense is -7.96% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

Evofem Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EVFM
CUSIP: 30048L
Website: evofem.com

Debt

Debt-to-Equity Ratio: -0.67
Current Ratio: 0.1
Quick Ratio: 0.06

Price-to-Earnings

Trailing P/E Ratio: 0.19
Forward P/E Ratio: 0

EVFM Technical Analysis vs Fundamental Analysis

Sell
29
Evofem Biosciences (EVFM) is a Sell

Is Evofem Biosciences a Buy or a Sell?